Major economic health benefit demonstrated for PromarkerD
Filed with ASX · · 3 pages · English
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- March 2021 Quarterly Activities Report and Appendix 4C
- ISO 13485 certification received - Manufacturing Update
- Response to Price Query
- Proteomics International seeks FDA approval for PromarkerD
- December 2020 Quarterly Activities Report and Appendix 4C
Later from Proteomics International Laboratories
- Proteomics secures major analytical services contract
- Modelling shows PromarkerD could save US payers $384 billion
- Suspension from Official Quotation
- Reinstatement to Official Quotation
- Study shows diabetes drug improves PromarkerD risk scores
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories